|
|
|
Insider
Information: |
Leiden Jeffrey M |
Relationship: |
Director |
City: |
Abbott Park |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
229,179 |
|
Indirect Shares
|
8,575 |
|
|
Direct
Value |
$30,036,725 |
|
|
Indirect Value
|
$280,851 |
|
|
Total
Shares |
237,754 |
|
|
Total
Value |
$30,317,576 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Abbott Laboratories |
ABT |
President and COO, Dir... |
2006-03-24 |
209,401 |
2006-03-24 |
635 |
Premium* |
|
Vertex Pharmaceuticals Inc |
VRTX |
Executive Chairman, Di... |
2024-02-20 |
13,778 |
2024-02-20 |
440 |
Premium* |
|
Quest Diagnostics Inc |
DGX |
Director |
2018-05-29 |
6,000 |
2014-12-01 |
0 |
Premium* |
|
Revolution Healthcare Acquisitio... |
REVH |
Director |
|
0 |
2021-03-17 |
7,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-05-24 |
4 |
OE |
$77.31 |
$8,769,428 |
D/D |
113,432 |
219,719 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-05-24 |
4 |
AS |
$175.10 |
$19,861,943 |
D/D |
(113,432) |
106,287 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-06-18 |
4 |
AS |
$175.33 |
$9,827,054 |
D/D |
(56,030) |
106,287 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-06-18 |
4 |
OE |
$77.31 |
$4,331,679 |
D/D |
56,030 |
162,317 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-10-22 |
4 |
AS |
$190.00 |
$20,487,890 |
D/D |
(107,831) |
106,287 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-10-22 |
4 |
OE |
$109.14 |
$12,574,276 |
D/D |
107,831 |
141,698 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-10-31 |
4 |
OE |
$131.89 |
$1,171,051 |
D/D |
8,879 |
115,166 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-10-31 |
4 |
AS |
$200.00 |
$1,775,800 |
D/D |
(8,879) |
106,287 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-11-01 |
4 |
OE |
$109.14 |
$11,170,756 |
D/D |
96,822 |
132,819 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-11-01 |
4 |
AS |
$200.00 |
$19,365,992 |
D/D |
(96,822) |
106,287 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-11-15 |
4 |
AS |
$210.00 |
$1,050,000 |
D/D |
(5,000) |
106,346 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-11-15 |
4 |
OE |
$109.14 |
$583,988 |
D/D |
5,000 |
108,029 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-11-18 |
4 |
OE |
$109.14 |
$517,893 |
D/D |
4,434 |
107,839 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2019-11-18 |
4 |
AS |
$210.00 |
$931,140 |
D/D |
(4,434) |
106,346 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2020-02-10 |
4 |
D |
$240.95 |
$8,856,117 |
D/D |
(36,755) |
180,063 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2020-02-11 |
4 |
AS |
$243.37 |
$11,694,933 |
D/D |
(47,523) |
132,540 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2020-02-17 |
4 |
D |
$241.50 |
$2,249,331 |
D/D |
(9,314) |
123,226 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2020-02-18 |
4 |
AS |
$241.78 |
$2,845,518 |
D/D |
(11,685) |
111,541 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2020-02-24 |
4 |
D |
$239.23 |
$2,011,924 |
D/D |
(8,410) |
103,131 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2020-02-25 |
4 |
AS |
$229.77 |
$2,463,046 |
D/D |
(10,550) |
92,581 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
|
2020-03-31 |
4 |
D |
$234.01 |
$9,381,461 |
D/D |
(40,090) |
52,491 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
|
2020-05-05 |
4 |
OE |
$91.05 |
$12,175,273 |
D/D |
88,537 |
141,028 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
|
2020-05-05 |
4 |
AS |
$265.57 |
$25,475,037 |
D/D |
(94,372) |
46,656 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
|
2020-05-07 |
4 |
OE |
$91.05 |
$12,174,982 |
D/D |
88,534 |
135,190 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
|
2020-05-07 |
4 |
AS |
$267.52 |
$25,459,013 |
D/D |
(94,369) |
40,821 |
0 |
% |
|
136 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|